Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.
about
Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancerEphrinB1: novel microtubule associated protein whose expression affects taxane sensitivityInitiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model.CSCdb: a cancer stem cells portal for markers, related genes and functional informationMetastatic model of HPV+ oropharyngeal squamous cell carcinoma demonstrates heterogeneity in tumor metastasis.
P2860
Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Targeting ERBB receptors shift ...... gh a novel ERBB/EFNB1 complex.
@en
type
label
Targeting ERBB receptors shift ...... gh a novel ERBB/EFNB1 complex.
@en
prefLabel
Targeting ERBB receptors shift ...... gh a novel ERBB/EFNB1 complex.
@en
P2093
P2860
P1433
P1476
Targeting ERBB receptors shift ...... gh a novel ERBB/EFNB1 complex.
@en
P2093
Bryant G Wieking
Daniel W Vermeer
John H Lee
Paola D Vermeer
Paul L Colbert
P2860
P304
P356
10.1158/0008-5472.CAN-13-0760
P407
P577
2013-06-28T00:00:00Z